This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Max-Delbruck-Centrum Fur Molekulare Medizin in Der Helmholtz-Gemeinschaft. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Krystyna Dudaniec - Innovator in Immunotherapy
Introduction
Krystyna Dudaniec is an accomplished inventor based in Szczecin, Poland. She is currently affiliated with the Max Delbrück Center for Molecular Medicine in the Helmholtz Association. Her work primarily focuses on immunotherapy, particularly in relation to Epstein-Barr virus-associated diseases.
Latest Patent Applications
Krystyna Dudaniec has filed a patent application titled "TCR Constructs Specific for EBV-Derived Antigens." This invention pertains to the field of immunotherapy, specifically targeting Epstein-Barr virus-associated diseases such as cancer and post-transplant lymphoproliferative disease. The application details a combination of nucleic acids encoding at least two TCR constructs, which are designed to bind specifically to their respective epitopes in the context of MHC I. The invention also includes specific nucleic acids encoding TCR alpha and beta chain constructs that are specific for epitopes of Epstein-Barr virus proteins.
Conclusion
Krystyna Dudaniec's contributions to the field of immunotherapy highlight her innovative approach to tackling complex medical challenges. Her ongoing research and patent applications reflect her commitment to advancing medical science and improving patient outcomes.